title: Cutaneous Mycobacterium haemophilum infection in a patient receiving infliximab for psoriasis.
authors: A
authors: A
authors: Aslam
authors: R L
authors: RL
authors: Green
authors: L
authors: L
authors: Motta
authors: M
authors: M
authors: Ghrew
authors: C E M
authors: CE
authors: Griffiths
authors: R B
authors: RB
authors: Warren
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003879:Dermatologic Agents / Q000009:adverse effects*; D006801:Humans; D000069285:Infliximab; D055985:Latent Tuberculosis / Q000139:chemically induced* / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D009164:Mycobacterium Infections / Q000139:chemically induced* / Q000382:microbiology; D018393:Mycobacterium haemophilum; D011565:Psoriasis / Q000188:drug therapy*; D014382:Tuberculosis, Cutaneous / Q000139:chemically induced* / Q000382:microbiology
chemical_list: D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D000069285:Infliximab